3-Hydroxybutanoic acid calcium salt

We are 3-Hydroxybutanoic acid calcium salt CAS:586976-56-9 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

CAS No: 586976-56-9
Product Name: 3-Hydroxybutanoic acid calcium salt
Other Name:
3-Hydroxybutanoic acid calcium salt
3-Hydroxybutyric acid calcium salt
Calcium beta-hydroxybutyrate
3-Hydroxybutyrate calcium
 
Molecular Formula: C8H14CaO6
Molecular Weight: 246.27100
 
Specification:
Appearance: White crystalline powder
Loss on drying: ≤4.0%
Heavy metals: ≤10ppm
Lead: ≤3ppm
Arsenic: ≤1ppm
Cadmium: ≤1ppm
Mercury: ≤0.1ppm
Assay: ≥98.0%
Calcium: 15%~19%
3-Hydroxybutanoic Acid: 81%~85%
Microbial
Total Plate Count: ≤1000cfu/g
Yeast&Mold: ≤100cfu/g
E.Coli: Negative in 10g
Salmonella: Negative in 10g
 
Application:
BHB as a nutritional supplement can increase blood ketone levels, improve athletes' endurance, mental performance and energy levels.
 
Package: 25kg/drum, can also be designed according to customer requirements.
Storage: Store in cool place. Keep container tightly closed in a dry and well-ventilated place.

3-Hydroxybutanoic acid calcium salt


Related News: The company’s short-term plan is to move from a purely chemical intermediate manufacturer to a formula active material supplier, and its long-term goal is to become a solution provider in the selected segment. In the future, this business is expected to become a new growth point for the company’s profit.223463-13-6 The company’s short-term plan is to move from a purely chemical intermediate manufacturer to a formula active material supplier, and its long-term goal is to become a solution provider in the selected segment. In the future, this business is expected to become a new growth point for the company’s profit.3-Bromo-5-nitropyridine In April 2019, Glenmark had received approval from the Drugs Controller General of India (DCGI) for Remogliflozin Etabonate after successfully completing Phase-3 clinical trials.3-Bromo-2-methoxypyridine CAS:13472-59-8 In April 2019, Glenmark had received approval from the Drugs Controller General of India (DCGI) for Remogliflozin Etabonate after successfully completing Phase-3 clinical trials.This is called API. A small amount of the active ingredient has an effect, so only a tiny part of the active ingredient is contained in medicine.

Related Products
Product Name
propane-2-thiol View Details
1,7-Heptanediol View Details
4-Amino-2-picoline View Details
2-Bromo-5-fluoroaniline manufacturer Diphenylsilanediol manufacturer 2-Chloroethyl Chloroformate manufacturer 1-Hydroxypyrene manufacturer (S)-1-(2-Amino-5-chlorophenyl)-1-(trifluoromethyl)-3-cyclopropyl-2-propyn-1-ol manufacturer